학술논문

EP08.01-012 First-line Chemo-Immunotherapy in Advanced Non-Small Cell Lung Cancer with 0-49% PD-L1: A Real-world Experience.
Document Type
Article
Source
Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS341-S341, 1p
Subject
Language
ISSN
15560864